<style type="text/css">.columns-container__full-width-background.banner__main-hero.background__main-hero {background-image: url("undefined")}@media only screen and (min-width:769px) { .columns-container__full-width-background.banner__main-hero.background__main-hero { background-image: url("undefined")}}</style>
Skip to main content
Dynamic Alerts
Site Logo
Health care professionals website
DPL Global Search
DPL Utility Nav
DPL Main Nav
DPL Global Search
DPL Utility Nav
Breadcrumbs
SubHero Banner
RxNews®
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Rinvoq® (upadacitinib) – New indication
April 29, 2025 - AbbVie announced the FDA approval of Rinvoq (upadacitinib), for the treatment of adults with giant cell arteritis.
